Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007360

Director acquired 20,776 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Robin L Director 2016-09-21 Option exercise +20,776 $5.00 $103,880 29,526 D
Derivatives
Smith Robin L Director 2016-09-21 Option exercise · 5% Secured Convertible Note due December 2017 −0 D
Smith Robin L Director 2016-09-21 Returned to the company · Common Stock Warrant −0 0 D
Loading xslF345X03/s104195_form4.xml…